{"entity":{"id":"microbiotica","kind":"company","name":"Microbiotica","aka":[],"tldr":"Microbiotica makes precisely defined mixtures of gut bacteria as medicines. Its lead product is given alongside immunotherapy to help more melanoma patients respond.","summary":"Microbiotica is a clinical-stage live biotherapeutic company at Chesterford Research Park, Cambridge, spun out of Trevor Lawley's laboratory at the Wellcome Sanger Institute. Its clinic-led platform profiles patient microbiomes at strain resolution to identify bacteria associated with clinical benefit, then formulates defined consortia. MB097 is a precision microbiome co-therapy for advanced melanoma given with anti-PD-1 therapy; the international phase 1b MELODY-1 trial completed recruitment in September 2025 and positive results were announced in May 2026. MB310 is a defined consortium for ulcerative colitis with positive phase 1b COMPOSER-1 results in February 2026. The company reports GBP 62 million of equity investment to date, including a GBP 50 million Series B in 2022.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://www.microbiotica.com"},{"label":"About (funding and origins)","url":"https://microbiotica.com/about/"},{"label":"Press releases","url":"https://microbiotica.com/press-releases/"}],"tags":[],"related":[],"cancers":["melanoma"],"sections":["immunotherapy"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Series B investors not named on fetched pages. Founding year not sourced."],"hq":"Cambridge","country":"GB","companyType":"biotech","website":"https://www.microbiotica.com","stage":"startup","investors":[],"funding":[{"round":"Series B","year":2022,"source":"https://microbiotica.com/about/","note":"GBP 50 million; GBP 62 million equity raised to date per company"}]},"route":"/companies/microbiotica/","neighbours":{"cancer":[{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"}],"section":[{"id":"immunotherapy","kind":"section","name":"Immunotherapy","route":"/fronts/immunotherapy/"}]}}